Logotipo do repositório
 

Publicação:
Femur bone repair in ovariectomized rats under the local action of alendronate, hydroxyapatite and the association of alendronate and hydroxyapatite

dc.contributor.authorVictor Canettieri, Antonio Carlos [UNESP]
dc.contributor.authorDias Colombo, Carlos Eduardo [UNESP]
dc.contributor.authorChin, Chung Man [UNESP]
dc.contributor.authorFaig-Leite, Horacio [UNESP]
dc.contributor.institutionUniv Vale Paraiba UNIVAP
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniv Taubate UNITAU
dc.date.accessioned2014-05-20T14:04:38Z
dc.date.available2014-05-20T14:04:38Z
dc.date.issued2009-10-01
dc.description.abstractP>An evaluation was made of the local action of alendronate sodium (A), hydroxyapatite (HA) and the association of both substances (A + HA), in different molar concentrations, on the femur bone repair of ovariectomized rats. Ninety-eight animals were divided into seven groups: control (C), starch (S), alendronate 1 mol (A1), alendronate 2 mols (A2), hydroxyapatite 1 mol (HA1), hydroxyapatite 2 mols (HA2) and the association of alendronate + hydroxyapatite (A + HA). Rats weighing about 250 g were ovariectomized and 2.5-mm diameter bone defects were made on the left femur 30 days later. Each experimental group had defects filled with appropriate material, except for group C (control). The animals were killed 7 and 21 days after surgery. Histological, histomorphometric and statistical analyses of bone neoformation in the bone defect site were performed. From the histological standpoint, the major differences occurred after 21 days. All specimens in groups C, S, HA1 and HA2 presented linear closure of the bone defect, and most animals in groups A1, A2 and A + HA showed no bone neoformation in the central area of the defect. No statistically significant difference was found among the experimental groups after 7 days; after 21 days, group HA2 presented the highest amount of neoformed bone. There was no significant difference among groups A1, A2 and A + HA in the two study periods. It was concluded that alendronate, either isolated or in association with hydroxyapatite, had an adverse effect on bone repair in this experimental model. Moreover, the hydroxyapatite used here proved to be biocompatible and osteoconductive, with group HA2 showing the best results.en
dc.description.affiliationUniv Vale Paraiba UNIVAP, Dept Hlth Sci, Sao Jose Dos Campos, SP, Brazil
dc.description.affiliationSão Paulo State Univ UNESP, Dept Biosci & Oral Diag, Sao Jose Dos Campos, SP, Brazil
dc.description.affiliationUniv Taubate UNITAU, Dept Dent, Taubate, SP, Brazil
dc.description.affiliationSão Paulo State Univ UNESP, Dept Pharmaceut Sci, Araraquara, SP, Brazil
dc.description.affiliationUnespSão Paulo State Univ UNESP, Dept Biosci & Oral Diag, Sao Jose Dos Campos, SP, Brazil
dc.description.affiliationUnespSão Paulo State Univ UNESP, Dept Pharmaceut Sci, Araraquara, SP, Brazil
dc.format.extent520-526
dc.identifierhttp://dx.doi.org/10.1111/j.1365-2613.2009.00674.x
dc.identifier.citationInternational Journal of Experimental Pathology. Malden: Wiley-blackwell Publishing, Inc, v. 90, n. 5, p. 520-526, 2009.
dc.identifier.doi10.1111/j.1365-2613.2009.00674.x
dc.identifier.issn0959-9673
dc.identifier.lattes9734333607975413
dc.identifier.orcid0000-0003-4141-0455
dc.identifier.urihttp://hdl.handle.net/11449/22681
dc.identifier.wosWOS:000269977100006
dc.language.isoeng
dc.publisherWiley-Blackwell Publishing, Inc
dc.relation.ispartofInternational Journal of Experimental Pathology
dc.relation.ispartofjcr1.938
dc.relation.ispartofsjr0,712
dc.rights.accessRightsAcesso restritopt
dc.sourceWeb of Science
dc.subjectalendronateen
dc.subjectbisphosphonatesen
dc.subjectbone repairen
dc.subjecthistomorphometryen
dc.subjecthydroxyapatiteen
dc.subjectratsen
dc.titleFemur bone repair in ovariectomized rats under the local action of alendronate, hydroxyapatite and the association of alendronate and hydroxyapatiteen
dc.typeArtigopt
dcterms.licensehttp://olabout.wiley.com/WileyCDA/Section/id-406071.html
dcterms.rightsHolderWiley-blackwell Publishing, Inc
dspace.entity.typePublication
relation.isDepartmentOfPublicatione214da1b-9929-4ae9-b8fd-655e9bfeda4b
relation.isDepartmentOfPublication.latestForDiscoverye214da1b-9929-4ae9-b8fd-655e9bfeda4b
relation.isOrgUnitOfPublication95697b0b-8977-4af6-88d5-c29c80b5ee92
relation.isOrgUnitOfPublication.latestForDiscovery95697b0b-8977-4af6-88d5-c29c80b5ee92
unesp.author.lattes9734333607975413[3]
unesp.author.orcid0000-0003-4141-0455[3]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Ciências Farmacêuticas, Araraquarapt
unesp.departmentFármacos e Medicamentos - FCFpt

Arquivos

Licença do Pacote

Agora exibindo 1 - 2 de 2
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: